ZIMLAB

Zim Laboratories Share Price

₹118.90 -1.7 (-1.41%)

20 Jul, 2025 08:36

SIP TrendupStart SIP in ZIMLAB

Start SIP

Performance

  • Low
  • ₹118
  • High
  • ₹127
  • 52 Week Low
  • ₹79
  • 52 Week High
  • ₹129
  • Open Price₹123
  • Previous Close₹121
  • Volume980,447

Investment Returns

  • Over 1 Month + 13.02%
  • Over 3 Month + 33%
  • Over 6 Month + 12.49%
  • Over 1 Year + 11.07%
SIP Lightning

Smart Investing Starts Here Start SIP with Zim Laboratories for Steady Growth!

Invest Now

Zim Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 47.6
  • PEG Ratio
  • -1.6
  • Market Cap Cr
  • 579
  • P/B Ratio
  • 2.3
  • Average True Range
  • 5.17
  • EPS
  • 2.5
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.79
  • RSI
  • 65.99
  • MFI
  • 81.65

Zim Laboratories Financials

Zim Laboratories Technicals

EMA & SMA

Current Price
₹118.90
-1.7 (-1.41%)
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹112.40
  • 50 Day
  • ₹105.49
  • 100 Day
  • ₹101.29
  • 200 Day
  • ₹101.29

Resistance and Support

121.23 Pivot Speed
  • R3 133.72
  • R2 130.33
  • R1 124.62
  • S1 115.52
  • S2 112.13
  • S3 106.42

What's your outlook on Zim Laboratories?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Zim Laboratories has an operating revenue of Rs. 379.03 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 5% is okay, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 17% and 19% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Zim Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-20 Audited Results
2025-02-10 Quarterly Results
2024-11-09 Quarterly Results
2024-08-03 Quarterly Results
2024-05-13 Audited Results
Date Purpose Remarks
2022-12-22 Bonus Rs.0.00 issue in the ratio of 2:1 of Rs. 10/-

Zim Laboratories F&O

Zim Laboratories Shareholding Pattern

33.26%
0.03%
47.5%
19.21%

About Zim Laboratories

  • NSE Symbol
  • ZIMLAB
  • BSE Symbol
  • 541400
  • Chairman & Managing Director
  • Dr. Anwar Daud
  • ISIN
  • INE518E01015

Similar Stocks to Zim Laboratories

Zim Laboratories FAQs

Zim Laboratories share price is ₹118 As on 20 July, 2025 | 08:22

The Market Cap of Zim Laboratories is ₹579.3 Cr As on 20 July, 2025 | 08:22

The P/E ratio of Zim Laboratories is 47.6 As on 20 July, 2025 | 08:22

The PB ratio of Zim Laboratories is 2.3 As on 20 July, 2025 | 08:22

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23